Sebi proposes changes to regulations regarding debenture trustees

Sebi proposes changes to regulations regarding debenture trustees


At present, there are restrictions on appointment of an entity as a DT in case of a certain level of pecuniary relationship with the issuer.


Markets regulator Sebi on Wednesday proposed certain changes to regulations related to debenture trustees.


A consultation paper has been issued to provide clarity on the term ‘pecuniary relationship’ of Debenture Trustee (DT) with the issuer under the existing norms and stakeholders can submit their comments till September 11.


At present, there are restrictions on appointment of an entity as a DT in case of a certain level of pecuniary relationship with the issuer.


The curbs will be applicable if the entity’s pecuniary relationship with the issuer amounts to 2 per cent or more of its gross turnover or total income or Rs 50 lakh or such higher amount as may be prescribed, whichever is lower.


The gross income will be calculated for the two immediately preceding financial years or during the current financial year.


Against this backdrop, some DTs have sought clarity on whether the remuneration being drawn by DTs from the issuer is included or excluded from the purview of ‘pecuniary relationship’ at the time of ascertaining eligibility.


A working group set up by Sebi suggested that remuneration payable to DTs should not be considered while assessing the pecuniary relationship of the DT with the issuer.


In the consultation paper, the regulator has proposed to exclude pecuniary relationship from computation of remuneration payable to DTs is appropriate and adequate.


There is also the proposal for “disclosure of remuneration/revenue received in respect of debenture trusteeship services as a percentage of the total remuneration/ revenue received by DT from the said issuer in respect of all services (including services other than the debenture trusteeship services)”.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Aug 21 2024 | 8:53 PM IST



Source link

Brokerages discontinued referral programmes post NSE's prohibition

Brokerages discontinued referral programmes post NSE's prohibition



Several brokerages have discontinued their referral programmes after a circular issued by top bourse National Stock Exchange (NSE) prohibited them from offering incentives to referrers unless they are registered authorised persons (APs).


“With a view to safeguard the interest of investors, it is hereby clarified that any person referring a client to the trading member (TM) shall be appointed as an AP of the TM after obtaining specific prior approval from the stock exchange for each such person,” NSE said in a circular on August 14.


An AP is an individual or entity appointed by a TM to provide access to a client to the trading platform. The circular puts the onus on brokers to ensure APs comply with Sebi and exchange rules.


The NSE’s move, according to industry insiders, may be aimed at preventing referrals from being exploited to lure clients into trading, rather than just opening accounts.


According to market buzz, most leading brokerages have decided to stop buying incentives to their clients for referring a new member. Such referral programmes have helped the industry add 27 million new demat accounts during the first seven months of 2023, taking the total count to 167 million.


“This is another one of those circulars that will hurt the business,” wrote Nitin Kamath, founder and CEO of Zerodha, in a LinkedIn post announcing the discontinuation of the firm’s referral scheme.


“We will stop our referral programme and make one-time payouts for whatever is due. However, we will continue to offer reward points for referrals, redeemable (at) partner products,” Kamath wrote.


Kamath added that to date, 1.24 million of Zerodha’s customers have referred at least one client.


Industry sources said new age brokerages would be most affected as 10-25 per cent of their customers were acquired through referrals.


Established brokers may benefit from the increased revenue, but experts argue that the move will hinder customer growth. Prakash Gagdani, CEO of Taurus Financial Market, stated, “The circular will detrimentally impact customer acquisition. Becoming an AP is a manual process, and why should a normal customer become a sub-broker?”

First Published: Aug 21 2024 | 8:49 PM IST



Source link

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg


Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New Drug Application (ANDA) for Lofexidine Tablets 0.18 mg to market a generic equivalent of Lucemyra Tablets, 0.18 mg of USWM, LLC.

Indoco has been granted a Competitive Generic Therapy (CGT) designation by the USFDA and being the first approved generic, is eligible for 180 days of CGT exclusivity for Lofexidine Tablets, 0.18 mg in the USA. This exclusivity will begin to run from the date of the first commercial marketing of the product. Indoco intends to launch the product immediately in the USA.

This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa – 403722 in India.

This product is indicated for mitigation of symptoms associated with acute withdrawal from opioids and for facilitation of the completion of opioid discontinuation treatment

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 21 2024 | 7:58 PM IST



Source link

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Hindustan Zinc to collaborate with JNCASR, Govt. of India


To develop new variants of zinc materials for next-generation zinc-based batterie

Hindustan Zinc has signed a Memorandum of Understanding (MoU) with Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), a premier institute sponsored by the Department of Science and Technology, Government of India. This collaboration aims to develop new variants of zinc materials to propel the commercialization of zinc-based batteries.

The partnership between Hindustan Zinc and JNCASR marks a pivotal moment in the evolution of battery technologies, leveraging zinc’s abundant resource availability, cost effectiveness and sustainable practices. At present, lithium-ion batteries dominate the market but lithium availability, geographic concentration of mineral processing, and concerns around safety relating to combustion issues pose some key challenges to the advancement of sustainable energy solutions. Above all, lithium is far costlier (more than four times) compared to zinc which is much more affordable. Zinc-based batteries are better alternatives to lithium based batteries mainly due to properties like long duration storage, cost-effectiveness, durability and proven safety track record.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 21 2024 | 7:55 PM IST



Source link

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

BEML signs MoU with Indian Navy for strengthening indigenous marine engineering capabilities


BEML has signed a strategic Memorandum of Understanding (MoU) today with the Directorate of Marine Engineering, Indian Navy.

This landmark agreement is a pivotal step in enhancing bilateral cooperation for the Indigenous Design, Development, Manufacture, Testing, and Product Support of critical Marine Equipment and systems. Aligned with the Government of India’s Aatmanirbhar Bharat initiative, the partnership aims to strengthen self-reliance in defence production and minimize reliance on foreign imports.

The equipment covered under this MoU will leverage BEML’s inherent strengths in heavy engineering, structural fabrication, hydraulics, diesel engines, manufacturing, testing, and R&D to bolster India’s maritime assets. BEML is committed to providing cost-effective, reliable, and enduring solutions to the Indian Navy, in alignment with the Government of India’s Aatmanirbhar Bharat initiative.

The collaboration between BEML and the Indian Navy is set to significantly enhance indigenous marine engineering capabilities, ensuring that both current and future naval projects are equipped with state-of-the-art, domestically produced technology. This strategic alliance is focused on meeting immediate operational requirements while also fortifying long-term defence infrastructure.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

First Published: Aug 21 2024 | 7:51 PM IST



Source link

Sebi's rights issue revamp may require tightrope walk

Sebi's rights issue revamp may require tightrope walk



The Securities and Exchange Board of India (Sebi) has set an ambitious target of reducing the rights issue timeline to less than a month from over four months at present, which has drawn praise from market experts, but also raised concerns.


The proposal to eliminate the need for appointing an investment bank may open up risks of improper and poor-quality disclosures and potential conflicts of interest, warn legal experts.


In a bid to increase its appeal vis-à-vis other fund-raising avenues available for listed companies, Sebi on Tuesday proposed a slew of changes to the rights issue framework. They will be formalised once the regulator gathers feedback and will not alter the near-term capital-raising plans of companies.


“These steps, while would reduce the timelines envisaged in completing the process, may impact the quality of the disclosures being done and increase the risk of misleading or inaccurate information,” said Sangeeta Jhunjhunwala, Partner, Khaitan Legal Associates.


 “The move is aimed at providing liquidity to issuers timely and without any regulatory hurdles, however, the interests of investors need to be also safeguarded while moving from an ‘approval-based’ to ‘intimation-based’ process,” she added.


At present, merchant bankers are tasked with conducting due diligence, preparing draft letters of offer, and documentation for filing with exchanges and Sebi. The market regulator plans doing away with some of these steps or shifting the roles to stock exchanges, and thus reducing the responsibilities. 


“Investor risks may rise in the event that merchant bankers do not conduct independent due diligence since they provide crucial experience and objectivity to the process. Moreover, issuers might not have the know-how to carry out exhaustive due diligence on their own, which could result in mistakes or oversights,” said Kunal Sharma, Partner, Singhania & Co.


Sharma added that conflict of interest may arise during validation of applications and finalisation of the basis of allotment by stock exchanges and depositories.


“If these entities are involved in both validation and allotment, they may prioritise their own or issuers interests ahead of that of investors’,” he said.


However, eliminating the appointment of merchant bankers is key for crunching the timelines.


According to the consultation paper by Sebi, merchant bankers take around 50 to 60 days to conduct due-diligence and prepare detailed offer documents. 


Sebi has proposed doing away with the requirement of due diligence certificate and filing of draft documents with the regulator.


“The responsibility for ensuring the accuracy of relevant disclosures would shift to the issuer, registrar to the issue and stock exchanges, warranting close attention to maintain the integrity of the disclosure process,” said Ketan Mukhija, Senior Partner, Burgeon Law.


To offer flexibility, Sebi has also proposed to allow renunciations of rights entitlement by shareholders to investors of their choice.


“Sebi has also proposed a very interesting framework for allotment to selective investors through renunciation by promoters or an allotment in case of under-subscription. This may potentially lead to some cannibalising of the preferential issue product, but some questions will need answering, including pricing aspects for such a transaction,” said Madhurima Mukherjee Saha, Partner, JSA Advocates & Solicitors.


Some legal players also pointed out that allowing allotment to specific investors may lead to opportunities for preferential treatment, which could diminish the rights of current shareholders.

First Published: Aug 21 2024 | 7:40 PM IST



Source link

YouTube
Instagram
WhatsApp